CHARLES SCHWAB INVESTMENT MANAGEMENT INC - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 60 filers reported holding LOGICBIO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$27,000
-49.1%
11,4980.0%0.00%
Q3 2021$53,000
-82.1%
11,498
-71.7%
0.00%
Q1 2021$296,000
+13.4%
40,646
+18.9%
0.00%
Q4 2020$261,000
+10.6%
34,198
+31.9%
0.00%
Q3 2020$236,000
+7.3%
25,9200.0%0.00%
Q2 2020$220,000
+144.4%
25,920
+42.7%
0.00%
Q1 2020$90,000
-31.3%
18,1690.0%0.00%
Q4 2019$131,000
-33.5%
18,1690.0%0.00%
Q3 2019$197,000
-32.8%
18,169
-19.2%
0.00%
Q2 2019$293,000
+44.3%
22,484
+9.6%
0.00%
Q1 2019$203,000
+20.1%
20,515
+26.6%
0.00%
Q4 2018$169,00016,2000.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Orbimed Advisors 8,466,783$5,758,0000.09%
HARBOR CAPITAL ADVISORS, INC. 226,731$154,0000.07%
Sio Capital Management, LLC 182,630$124,0000.04%
Virtu Financial LLC 71,475$49,0000.00%
Independence Bank of Kentucky 10,200$7,0000.00%
SANDERS MORRIS HARRIS LLC 15,000$10,0000.00%
Endurance Wealth Management, Inc. 1,500$12,0000.00%
Baker Brothers Advisors 451,478$307,0000.00%
Texas Yale Capital Corp. 20,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 79,900$54,0000.00%
View complete list of LOGICBIO THERAPEUTICS INC shareholders